P Frandsen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P Frandsen

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Biotechnology and Bioengineering|April 6, 2006

Production of target-specific recombinant human polyclonal antibodies in mammalian cellsFinn C Wiberg, Søren K Rasmussen, Torben P Frandsen, et al.

Biotechnology and Bioengineering|April 16, 2011

Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic useTorben P Frandsen, Henrik Naested, Søren K Rasmussen, et al.

Blood|August 24, 2012

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopeniaTadeusz Robak, Jerzy Windyga, Jacek Trelinski, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Biotechnology and Bioengineering|April 6, 2006

Production of target-specific recombinant human polyclonal antibodies in mammalian cellsFinn C Wiberg, Søren K Rasmussen, Torben P Frandsen, et al.

Biotechnology and Bioengineering|April 16, 2011

Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic useTorben P Frandsen, Henrik Naested, Søren K Rasmussen, et al.

Blood|August 24, 2012

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopeniaTadeusz Robak, Jerzy Windyga, Jacek Trelinski, et al.

Pageof 4